Literature DB >> 9387181

Treatment of congenital nasolacrimal duct obstruction before and after the age of 1 year.

J Zwaan1.   

Abstract

BACKGROUND AND OBJECTIVES: The treatment of congenital nasolacrimal duct (NLD) obstruction continues to be a subject of controversy. Some authors advocate early probing and irrigation in an office setting, whereas others recommend that the procedure be performed under general anesthesia when the child is at least 1 year old. The focus of this study was to compare the results of probing and irrigation of congenital NLD obstruction among children younger than 1 year of age, those 1 to 2 years of age, and those older than 2 years. PATIENTS AND METHODS: The author reviewed the records of 120 patients, ranging in age from 3 weeks to 30 years, with 153 cases of NLD obstruction. Eighty-five patients (110 cases of NLD obstruction) underwent probing and irrigation.
RESULTS: Complications of NLD obstruction occurred in 12 patients; 75% of these patients were younger than 1 year of age. In group 1 (patient age < 1 year) there were 37 probings with 1 failure (3%). Group 2 (patient age = 1-2 years) had 43 probings and 5 failures (12%). In group 3 (patient age > 2 years), 30 NLDs were probed with 2 failures (7%). However, these differences were not significant (P = .13 between groups 1 and 2; P = .42 between groups 1 and 3).
CONCLUSION: In this study, the postponement of probing and irrigation for congenital NLD obstruction beyond the age of 1 year did not result in an increased rate of failures or complications.

Entities:  

Mesh:

Year:  1997        PMID: 9387181

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  11 in total

1.  Ophthaproblem. Congenital nasolacrimal duct obstruction.

Authors:  S Sharma
Journal:  Can Fam Physician       Date:  1998-10       Impact factor: 3.275

2.  Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.

Authors:  Masahiro Fujimoto; Ken Ogino; Hiroko Matsuyama; Chika Miyazaki
Journal:  Jpn J Ophthalmol       Date:  2016-04-27       Impact factor: 2.447

3.  The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.

Authors:  Yanir Kassif; Uri Rehany; Michal David; Anna Popko; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

4.  The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age.

Authors:  Hirohiko Kakizaki; Yasuhiro Takahashi; Shinsuke Kinoshita; Kunihiko Shiraki; Masayoshi Iwaki
Journal:  Clin Ophthalmol       Date:  2008-06

5.  Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.

Authors:  Piero Steindler; Enrico Mantovani; Carlo Incorvaia; Francesco Parmeggiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-24       Impact factor: 3.117

6.  The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.

Authors:  Omer Karti; Eyyup Karahan; Durgul Acan; Tuncay Kusbeci
Journal:  Int Ophthalmol       Date:  2016-03-07       Impact factor: 2.031

7.  Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?

Authors:  M B Kashkouli; B Beigi; M M Parvaresh; A Kassaee; Z Tabatabaee
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

8.  Clinical profile of the patients with pediatric epiphora in a tertiary eye care center.

Authors:  Rebika Dhiman; Bhavna Chawla; Mahesh Chandra; Mandeep S Bajaj; Neelam Pushker
Journal:  Indian J Ophthalmol       Date:  2017-01       Impact factor: 1.848

9.  Outcomes and comparison of nasolacrimal probing for patients older than 12 months.

Authors:  Kürsad Ramazan Zor; Erkut Küçük; Zeynep Yılmaz Öztorun
Journal:  Ther Adv Ophthalmol       Date:  2020-06-26

10.  Tobramycin/dexamethasone eye drops as a better choice for lacrimal duct probing in persistent congenital nasolacrimal duct obstruction: A consort study.

Authors:  Qin Xiang; Dan Hu; Xu Gao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.